Literature DB >> 11251368

Significance of basal IGF-I, IGFBP-3 and IGFBP-2 measurements in the diagnostics of short stature in children.

M B Ranke1, R Schweizer, M W Elmlinger, K Weber, G Binder, C P Schwarze, H A Wollmann.   

Abstract

The role of IGF-I and IGFBP-3 measurements in the diagnostic work-up of short children is established but remains controversial. Little information exists on the value of IGFBP-2 measurements. Based on reference data established in 388 children we have reinvestigated the issue, using data from 392 short children who underwent the same diagnostic procedures between 1987 and 1998 (GHD, n = 187; non-GHD, n = 205, including patients with ISS, n = 76; IUGR, n = 46; and TS, n = 83). In comparing IGF-I, IGFBP-3 and IGFBP-2 serum levels of GHD and ISS children with reference data, we calculated the sensitivity, specificity, efficiency and positive predictive value for the diagnosis of GHD. The overall sensitivity of the parameters was high, the rank order being as follows: IGF-I >IGFBP-3 >IGFBP-2 (75, 67 and 62%, respectively). In contrast, the specificity was relatively low: IGFBP-3 >IGFBP-2 >IGF-I (50, 50 and 32%, respectively). The efficiency and positive predictive value of parameters was in the order of 40, 60 and 70--80%, respectively. In repeated measurements, the recorded basal levels of IGF-I and IGFBP-3 showed an overall narrow range of variation. We conclude that the determination of basal IGF parameters is, together with anthropometry and imaging techniques, an indispensable tool for differentiating between GHD and ISS; and that IGFBP-2 plays an additional role in this process. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11251368     DOI: 10.1159/000053233

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  15 in total

1.  More guidance on growth hormone deficiency.

Authors:  R Ayling
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

Review 2.  Assessment of serum IGF-I concentrations in the diagnosis of isolated childhood-onset GH deficiency: a proposal of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED).

Authors:  G Federico; M E Street; M Maghnie; M Caruso-Nicoletti; S Loche; S Bertelloni; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

3.  Serum IGF-binding protein 2 (IGFBP-2) concentrations change early after gastric bypass bariatric surgery revealing a possible marker of leptin sensitivity in obese subjects.

Authors:  Giovanni Ceccarini; Caterina Pelosini; Federica Ferrari; Silvia Magno; Jacopo Vitti; Guido Salvetti; Carlo Moretto; Antonio Marioni; Piero Buccianti; Paolo Piaggi; Margherita Maffei; Ferruccio Santini
Journal:  Endocrine       Date:  2019-04-03       Impact factor: 3.633

4.  Vascular endothelial growth factor (VEGF) levels in short, GH treated children: a distinct pattern of VEGF-C in Noonan syndrome.

Authors:  S Fuchs; G Gat-Yablonski; B Shtaif; L Lazar; M Phillip; Y Lebenthal
Journal:  J Endocrinol Invest       Date:  2014-10-26       Impact factor: 4.256

Review 5.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

6.  Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on "Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time" by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625-38].

Authors:  Arlan L Rosenbloom
Journal:  Int J Pediatr Endocrinol       Date:  2010-02-08

7.  Pituitary function in children following infectious diseases of the central nervous system.

Authors:  Yael Levy-Shraga; Inbal Gazit; Dalit Modan-Moses; Orit Pinhas-Hamiel
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

Review 8.  Treatment of children and adolescents with idiopathic short stature.

Authors:  Michael B Ranke
Journal:  Nat Rev Endocrinol       Date:  2013-04-23       Impact factor: 43.330

Review 9.  Diagnostic value of serum IGF-1 and IGFBP-3 in growth hormone deficiency: a systematic review with meta-analysis.

Authors:  Yi Shen; Jian Zhang; Yanhong Zhao; Yu Yan; Yanmei Liu; Jin Cai
Journal:  Eur J Pediatr       Date:  2014-09-13       Impact factor: 3.183

10.  Do IGF-I concentrations better reflect growth hormone (GH) action in children with short stature than the results of GH stimulating tests? Evidence from the simultaneous assessment of thyroid function.

Authors:  Joanna Smyczyńska; Renata Stawerska; Andrzej Lewiński; Maciej Hilczer
Journal:  Thyroid Res       Date:  2011-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.